Trials / Terminated
TerminatedNCT00210028
Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
Open, Single-Arm Phase II Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer Expressing the Estrogen and/or Progesterone Receptor
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Institut Claudius Regaud · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the objective response rate when ZARNESTRA is added to treatment with tamoxifen
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamoxifen | |
| DRUG | Zarnestra |
Timeline
- Start date
- 2003-08-01
- Completion
- 2008-08-01
- First posted
- 2005-09-21
- Last updated
- 2006-11-14
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00210028. Inclusion in this directory is not an endorsement.